Severe agitation in severe early-onset Alzheimer’s disease resolves with ECT

Código QR

Severe agitation in severe early-onset Alzheimer’s disease resolves with ECT

Suna Su Aksay, Lucrezia Hausner, Lutz Frölich, Alexander Sartorius Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany Abstract: Dementia-related behavioral disturbances are mostly treated with...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Aksay SS, Hausner L, Frölich L, Sartorius A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/25c60030a5944ed8890096cc75f69b9f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia
por: Aksay SS, et al.
Publicado: (2017)

Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutions
por: Millán-Calenti JC, et al.
Publicado: (2016)

A review of ketamine’s role in ECT and non-ECT settings
por: Jankauskas V, et al.
Publicado: (2018)

A genetic screen of the mutations in the Korean patients with early-onset Alzheimer’s disease
por: An SS, et al.
Publicado: (2016)

Mutations, associated with early-onset Alzheimer’s disease, discovered in Asian countries
por: Bagyinszky E, et al.
Publicado: (2016)

Markers of neurodevelopmental impairments in early-onset psychosis
por: Petruzzelli MG, et al.
Publicado: (2015)

The efficacy of mirtazapine in agitated patients with Alzheimer&rsquo;s disease: A 12-week open-label pilot study
por: Sibel Cakir, et al.
Publicado: (2008)

Late onset Alzheimer’s disease in older people
por: Ahmet Turan Isik
Publicado: (2010)

Feasibility and efficacy of cognitive telerehabilitation in early Alzheimer’s disease: a pilot study
por: Jelcic N, et al.
Publicado: (2014)

Chinese version of Montreal Cognitive Assessment Basic for discrimination among different severities of Alzheimer’s disease
por: Huang L, et al.
Publicado: (2018)

Early-onset Alzheimer’s disease patient with prion (PRNP) p.Val180Ile mutation
por: Bagyinszky E, et al.
Publicado: (2019)

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer&rsquo;s disease
por: Umamon Puangthong, et al.
Publicado: (2009)

Bilingualism as a strategy to delay the onset of Alzheimer’s disease
por: Klimova B, et al.
Publicado: (2017)

Detection, diagnosis, and treatment of Alzheimer’s disease dementia stratified by severity as reported by caregivers in Japan
por: Montgomery W, et al.
Publicado: (2018)

Telomere length in blood cells is related to the chronicity, severity, and recurrence rate of schizophrenia
por: Pawelczyk T, et al.
Publicado: (2015)

PSEN1 L226F mutation in a patient with early-onset Alzheimer’s disease in Korea
por: Bagyinszky E, et al.
Publicado: (2016)

A case of possibly pathogenic PSEN2 R62C mutation in a patient with probable early-onset Alzheimer’s dementia supported by structure prediction
por: Park KW, et al.
Publicado: (2017)

Association analysis of polymorphisms in STARD6 and near ECHDC3 in Alzheimer’s disease patients carrying the APOE ε4 Allele
por: Yin J, et al.
Publicado: (2019)

A pathogenic PSEN2 p.His169Asn mutation associated with early-onset Alzheimer’s disease
por: Giau VV, et al.
Publicado: (2018)

Genomics of severe depression and ECT treatment response: scientific rationale, large scale standardised assessment and implementation of a world-wide effort
por: Bernhard Baune
Publicado: (2021)

Cerebrospinal fluid biomarkers for Alzheimer’s disease: the role of apolipoprotein E genotype, age, and sex
por: Mehrabian S, et al.
Publicado: (2015)

HERPESVIRUS INFECTIONS AND CLINICAL-IMMUNOLOGIC INTERACTIONS IN PATIENTS WITH EARLY-ONSET ALZHEIMER’S DISEASE AND LATE-ONSET ALZHEIMER’S DISEASE
por: I. K. Malashenkova, et al.
Publicado: (2021)

Tailored lighting intervention improves measures of sleep, depression, and agitation in persons with Alzheimer’s disease and related dementia living in long-term care facilities
por: Figueiro MG, et al.
Publicado: (2014)

Neuroanatomical abnormalities before onset of delusions in patients with Alzheimer&rsquo;s disease: a voxel-based morphometry study
por: Nakaaki S, et al.
Publicado: (2012)

Neuroinflammation in Alzheimer’s disease
por: Zhang FJ, et al.
Publicado: (2015)

Association of interleukin-33 gene polymorphisms with susceptibility to late onset Alzheimer’s disease: a meta-analysis
por: Zhong X, et al.
Publicado: (2017)

Memantine treatment for Japanese patients with moderate to severe Alzheimer’s disease: a meta-analysis of double-blind, randomized, placebo-controlled trials
por: Kishi T, et al.
Publicado: (2018)

Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia
por: Shintaro Sato, et al.
Publicado: (2021)

Prolonged cholinergic enrichment influences regional cortical activation in early Alzheimer&rsquo;s disease
por: William J McGeown, et al.
Publicado: (2008)

Estrogen receptor α gene polymorphisms and risk of Alzheimer’s disease: evidence from a meta-analysis
por: Cheng D, et al.
Publicado: (2014)

Diffusion tensor imaging investigations in Alzheimer&rsquo;s disease: the resurgence of white matter compromise in&nbsp;the cortical dysfunction of the aging brain
por: David A Medina, et al.
Publicado: (2008)

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer&#39;s disease in the Netherlands
por: Hoogveldt B, et al.
Publicado: (2011)

Solitary living in Alzheimer’s disease over 3 years: association between cognitive and functional impairment and community-based services
por: Wattmo C, et al.
Publicado: (2014)

Magnetic resonance spectroscopy in Alzheimer’s disease
por: Graff-Radford J, et al.
Publicado: (2013)

Olfactory dysfunction in Alzheimer’s disease
por: Zou YM, et al.
Publicado: (2016)

Role of berberine in Alzheimer’s disease
por: Cai Z, et al.
Publicado: (2016)

The severe complication of Stevens–Johnson syndrome induced by long-term clozapine treatment in a male schizophrenia patient: a case report
por: Wu MK, et al.
Publicado: (2015)

Efalizumab-induced severe thrombocytopenia can be resolved
por: Francesca Prignano, et al.
Publicado: (2008)

Baseline symptom profile does not predict early response to electroconvulsive therapy (ECT) in major depressive disorder (MDD)
por: Bijan Zarrabi, et al.
Publicado: (2021)

The consortium of Researchers for ECT (CORE) - past, present and future
por: Georgios Petrides
Publicado: (2021)